L’iboga. Un patrimoine naturel, culturel et national au service du monde
Claire Versuela Idomba Mboukouabo
Revue Sénégalaise des Sciences de l'Information. June 5, 2024 DOI: 10.61585/pud-ebad-rssi-v1n106 (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Review Peer reviewed |
|---|---|
| Topics | Ibogaine |
| Key findings | Iboga, a Gabonese national heritage used in traditional rituals, has its alkaloid ibogaine recognized by modern medicine for treating drug addiction, especially opioid addiction. |
Abstract
This article aims to present "iboga," also known as "sacred wood," as an endogenous knowledge used traditionally in the spiritual and medicinal rituals of the people of Gabon during initiation ceremonies such as bwiti, mumbwiri, and many other rites. This plant, considered a natural, cultural, and national heritage, allows for transcendence between physical and invisible worlds through its consumption in powdered form during an initiation ceremony. While Marc Kaba in "Voie sacrée" describes the psychological, social, and spiritual virtues of this plant through narration, medical science, through the National Institute on Drug Abuse (NIDA), began prescribing its substance (ibogaine) as part of a drug dependency treatment protocol for humans in the early 1990s. Thus, it highlights how this national heritage is an asset to modern medicine. Beyond its traditional uses, ibogaine (an alkaloid substance) has attracted international attention due to its potential for treating addiction, particularly opioid addiction and other substances. Keywords: Iboga, heritage, national, medicine, world
Comparable studies
Other narrative reviews on ibogaine, most cited first.
| Study | Year | Design | Participants |
|---|---|---|---|
| Psychedelics as medicines for substance abuse rehabilitation: evaluating treatments with LSD, Peyote, Ibogaine and Ayahuasca. | 2014 | Review | |
| The Anti-Addiction Drug Ibogaine and the Heart: A Delicate Relation Humans, animals | 2015 | Review | |
| Ibogaine in the treatment of substance dependence. | 2013 | Review | |
| Ibogaine, an anti-addictive drug: pharmacology and time to go further in development. A narrative review. | 2008 | Review | |
| Registered clinical studies investigating psychedelic drugs for psychiatric disorders. Registered clinical trials on clinicaltrials.gov evaluating psychedelics for... | 2021 | Review | n = 70 |